Literature DB >> 312499

Formation of 5-hydroxykynurenine and 5-hydroxykynurenamine from 5-hydroxytryptophan in rabbit small intestine.

M Fujiwara, M Shibata, Y Nomiyama, T Sugimoto, F Hirata, T Tokuyama, S Senoh, O Hayaishi.   

Abstract

In order to clarify the role of indoleamine 2,3-dioxygenase [indole:oxygen 2,3-oxidoreductase (decyclizing), EC 1.13.11.17] in the metabolism of serotonin, DL-5-hydroxy[methylene-(14)C]tryptophan, a precursor of serotonin, was incubated with slices of rabbit ileum. Resulting metabolites were separated by DEAE-cellulose column and polyamide column chromatography and identified by various chromatographic techniques and enzymatic analysis. Metabolites obtained in significant amounts were serotonin, 5-hydroxyindoleacetic acid, 5-hydroxytryptophol, 5-hydroxykynurenine, 5-hydroxykynurenamine, and 4,6-dihydroxyquinoline, representing 13.2, 15.8, 7.0, 21.9, 1.3, and 2.6% of the total metabolites, respectively. The first three compounds were previously reported to be major metabolites produced from 5-hydroxytryptophan by the action of aromatic L-amino acid decarboxylase and monoamine oxidase, whereas the last three are formed by the cleavage of the indole ring by the action of indoleamine 2,3-dioxygenase. In the presence of pargyline, a monoamine oxidase inhibitor, the major metabolites obtained were serotonin, 5-hydroxykynurenine, and 5-hydroxykynurenamine, representing 29.6, 26.6, and 5.4% of the total metabolites, respectively. In the presence of RO4-4602, an aromatic amino acid decarboxylase inhibitor, 5-hydroxykynurenine was the sole major product. These results strongly suggest that the newly discovered metabolic pathway involving the cleavage of the indole ring of 5-hydroxytryptophan operates in vivo to a significant extent and that indoleamine 2,3-dioxygenase plays an important role in the regulation of serotonin levels in the small intestine of the rabbit.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312499      PMCID: PMC383206          DOI: 10.1073/pnas.76.3.1145

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine.

Authors:  H WEISSBACH; T E SMITH; J W DALY; B WITKOP; S UDENFRIEND
Journal:  J Biol Chem       Date:  1960-04       Impact factor: 5.157

2.  Identification and assay of serotonin in brain.

Authors:  D F BOGDANSKI; A PLETSCHER; B B BRODIE; S UNDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

3.  The detection of mausamine in the brain of mouse.

Authors:  K MAKINO; Y JOH; F HASEGAWA
Journal:  Biochem Biophys Res Commun       Date:  1962-01-24       Impact factor: 3.575

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  The isolation and identification of 5-hydroxy-L-kynurenine from the urine of hens.

Authors:  R Kido; T Noguchi; Y Matsumura
Journal:  Biochim Biophys Acta       Date:  1967-07-25

6.  Reversal of hypotonia in infants with Down's syndrome by administration of 5-hydroxytryptophan.

Authors:  M Bazelon; R S Paine; V A Coeiw; P Hunt; J C Houck; D Mahanand
Journal:  Lancet       Date:  1967-05-27       Impact factor: 79.321

7.  An improved column chromatographic method for isolation of tryptophan metabolites.

Authors:  N C Chen; R K Gholson
Journal:  Anal Biochem       Date:  1972-05       Impact factor: 3.365

8.  [L-5-hydroxytryptophan(L-5-HTP) therapy of Parkinson's disease. 2].

Authors:  I Sano; K Taniguchi
Journal:  Munch Med Wochenschr       Date:  1972-10-06

9.  [L-5-hydroxytryptophan(L-5-HTP) therapy in endogenous depression. 1].

Authors:  I Sano
Journal:  Munch Med Wochenschr       Date:  1972-10-06

10.  Enzymic formation of D-kynurenine from D-tryptophan.

Authors:  K Higuchi; O Hayaishi
Journal:  Arch Biochem Biophys       Date:  1967-05       Impact factor: 4.013

View more
  8 in total

1.  L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression.

Authors:  Jing Huang; Xiaobo Wang; Bing Li; Shiyu Shen; Ruina Wang; Hongru Tao; Junchi Hu; Jin Yu; Hualiang Jiang; Kaixian Chen; Cheng Luo; Yongjun Dang; Yuanyuan Zhang
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

2.  Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan.

Authors:  Hiam Abdala-Valencia; Sergejs Berdnikovs; Christine A McCary; Daniela Urick; Riti Mahadevia; Michelle E Marchese; Kelsey Swartz; Lakiea Wright; Gökhan M Mutlu; Joan M Cook-Mills
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-27       Impact factor: 5.464

3.  Indoleamine 2,3-dioxygenase. A new, rapid, sensitive radiometric assay and its application to the study of the enzyme in rat tissues.

Authors:  J S Cook; C I Pogson; S A Smith
Journal:  Biochem J       Date:  1980-09-01       Impact factor: 3.857

4.  Evidence for presence of kynurenine in lung and brain of neonate hamsters.

Authors:  I M Keith; M S Brownfield
Journal:  Histochemistry       Date:  1985

5.  Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme.

Authors:  F Yamazaki; T Kuroiwa; O Takikawa; R Kido
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

6.  Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice.

Authors:  Angela W Corona; Diana M Norden; John P Skendelas; Yan Huang; Jason C O'Connor; Marcus Lawson; Robert Dantzer; Keith W Kelley; Jonathan P Godbout
Journal:  Brain Behav Immun       Date:  2012-08-19       Impact factor: 7.217

7.  Stereospecificity of hepatic L-tryptophan 2,3-dioxygenase.

Authors:  Y Watanabe; M Fujiwara; R Yoshida; O Hayaishi
Journal:  Biochem J       Date:  1980-09-01       Impact factor: 3.857

8.  The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels.

Authors:  S N Young; S Gauthier; G Chouinard; G M Anderson; W C Purdy
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.